Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotics for Prevention of VAP in Critically Ill Children
NCT07848165Recruiting
- Sponsor
- Tanta University
- Start
- Jul 2026
- Primary completion
- Feb 2027
- Countries
- 1
01
Overview
Trial in ventilator-associated pneumonia (VAP) (2 arms), sponsored by Tanta University. Primary endpoint: Incidence of ventilator-associated pneumonia at 28 days. Started Jul 2026; status: recruiting.
02
Conditions
ventilator-associated pneumonia (VAP)
Beyond the preview
Go deeper on NCT07848165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07848165.